CHINA GEWANG BIOTECHNOLOGY, INC.
company.status.inactiveCIK 1489902fmd_143EWQGK3CRVKTYXCFDJAKRYMTManufacturing · Food and Kindred ProductsTemplate: Standard
Coverage: Jan 01, 2010 to May 31, 2017, 33 periods
Latest annual · FY2016
Millions- Total revenues
- 46
- Gross profit
- 17
- Operating income
- 12
- Net income
- 14
Latest quarter · Q2 FY2017
Millions- Total revenues
- 22
- Gross profit
- 8
- Operating income
- 5
- Net income
- 6
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2014 to FY2016
- 0.0%
- Revenue, 5 yearsFY2013 to FY2016
- n/m
- Net income, 5 yearsFY2013 to FY2016
- n/m
CHINA GEWANG BIOTECHNOLOGY, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $45.5 million | $4.2 million | +987.9% | 10-K 2017-02-10 · proof |
| Gross profit | $16.8 million | $3 million | +458.9% | 10-K 2017-02-10 · proof |
| Operating income | $12.1 million | $1.6 million | +640.8% | 10-K 2017-02-10 · proof |
| Net income | $13.6 million | $1.2 million | +1,042% | 10-K 2017-02-10 · proof |
| Cash from operating activities | -$2.8 million | $1 million | -373.3% | 10-K 2017-02-10 · proof |
| Total assets | $36.2 million | $9.4 million | +286.8% | 10-K 2017-02-10 · proof |
| Total liabilities | $4.8 million | $5.2 million | -8.1% | 10-K 2017-02-10 · proof |
| Cash and cash equivalents | $13.1 million | $8.7 million | +51.2% | 10-K 2017-02-10 · proof |
- What was CHINA GEWANG BIOTECHNOLOGY, INC.'s revenue in fiscal 2016?
- CHINA GEWANG BIOTECHNOLOGY, INC. reported revenue of $45.5 million for fiscal 2016 (the year ended Nov 30, 2016), against $4.2 million the year before (+987.9%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
- What was CHINA GEWANG BIOTECHNOLOGY, INC.'s gross profit in fiscal 2016?
- CHINA GEWANG BIOTECHNOLOGY, INC. reported gross profit of $16.8 million for fiscal 2016 (the year ended Nov 30, 2016), against $3 million the year before (+458.9%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
- What was CHINA GEWANG BIOTECHNOLOGY, INC.'s operating income in fiscal 2016?
- CHINA GEWANG BIOTECHNOLOGY, INC. reported operating income of $12.1 million for fiscal 2016 (the year ended Nov 30, 2016), against $1.6 million the year before (+640.8%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
- What was CHINA GEWANG BIOTECHNOLOGY, INC.'s net income in fiscal 2016?
- CHINA GEWANG BIOTECHNOLOGY, INC. reported net income of $13.6 million for fiscal 2016 (the year ended Nov 30, 2016), against $1.2 million the year before (+1,042%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
- What was CHINA GEWANG BIOTECHNOLOGY, INC.'s cash from operating activities in fiscal 2016?
- CHINA GEWANG BIOTECHNOLOGY, INC. reported cash from operating activities of -$2.8 million for fiscal 2016 (the year ended Nov 30, 2016), against $1 million the year before (-373.3%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
- What are CHINA GEWANG BIOTECHNOLOGY, INC.'s total assets?
- As of Nov 30, 2016, CHINA GEWANG BIOTECHNOLOGY, INC. reported total assets of $36.2 million, against $9.4 million a year earlier (+286.8%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
- What are CHINA GEWANG BIOTECHNOLOGY, INC.'s total liabilities?
- As of Nov 30, 2016, CHINA GEWANG BIOTECHNOLOGY, INC. reported total liabilities of $4.8 million, against $5.2 million a year earlier (-8.1%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
- What are CHINA GEWANG BIOTECHNOLOGY, INC.'s cash and cash equivalents?
- As of Nov 30, 2016, CHINA GEWANG BIOTECHNOLOGY, INC. reported cash and cash equivalents of $13.1 million, against $8.7 million a year earlier (+51.2%). Source: the 10-K filed with the SEC on Feb 10, 2017. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1489902&period_type=annual&limit=5"Information only, not investment advice.